BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2230926, FOXP1, glucose metabolic process, Leukemia, Liver, Amniocentesis, Cisplatin)
Bookmark Forward

QuickView for CX3CL1 (gene)


Body Atlas

Most Correlated Tissues

  1. Mammary gland
  2. Whole brain
  3. Cingulate cortex
  4. Putamen
  5. Breast tissue
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Physical activity
  2. Body mass index
  3. Tobacco use and exposure (clinical finding)
  4. Breast cancer
  5. Ulceration of intestine
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Cytochalasin B
  2. Buthionine Sulfoximine
  3. Interleukin-1alpha
  4. Fatty Acid Synthesis Inhibitors
  5. Nortriptyline
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PCAT1
  2. OTUD1
  3. DUOX1
  4. RBM4
  5. SS18
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. CX3C chemokine: Hallmarks of fibrosis and ageing.
  2. Alterations in CX3CL1 Levels and Its Role in Viral Pathogenesis.
  3. CX3CL1 Regulation of Gliosis in Neuroinflammatory and Neuroprotective Processes.
  4. The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune…
  5. The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in o…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Crucumin Effects on the Immune System in Osteoarthritis Patients
  2. ECLAXIR:Search for an Association Between CX3CR1 V249I Polymorphism, Preeclampsia and Endothelial In…
  3. Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endoto…
  4. Role of CX3CR1-expressing Cells in Hematologic Malignancy
  5. Morphofunctional, Gene, Inflammation Molecules and Oxidative Stress Analysis in Kidney Tissue of COV…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.